Other groups observed that UPA is able to reverse E2 and P4 actions by decreasing breast cell proliferation and hormone receptor expression on BRCA1-mutated breast tissue xenografted in mice; suggesting that a subset of women with BRCA1 mutations could be candidates for UPA treatment as a preventive breast cancer strategy (46). Here, NR4A1 is linked to breast cancer.